Come visit our booth, where we’ll be happy to walk you through our diagnostic antibody development package – including CDx assay support and biomarker validation, built around the exact assay your diagnostic requires.

Come visit our booth, where we’ll be happy to walk you through our ADC-compatible therapeutic antibody development package – including epitope-rich fully human antibodies and anti-ID/anti-payload antibodies for your PK and ADA assay support.

Come visit our booth, where we’ll be happy to walk you through our therapeutic antibody development package – from antigen design through in vitro and in vivo assay support, including fully human monoclonal antibodies, all built around your therapeutic antibody needs.

We are happy to announce that our CEO, Dr. Ginette Serrero, will be giving an invited talk covering our approach to developing fully human anti-HER2 antibodies and their applications as ADCs.

Come visit our booth, where we’ll also be happy to walk you through our therapeutic antibody development package, from antigen design through in vitro and in vivo assay support, including fully human monoclonal antibodies, all built around your therapeutic antibody needs.

We are happy to announce that our CEO, Dr. Ginette Serrero, will be giving an invited talk covering our approach to developing fully human anti-HER2 antibodies and their applications as ADCs.

Come visit our booth, where we’ll also be happy to walk you through our therapeutic antibody development package, from antigen design through in vitro and in vivo assay support, including fully human monoclonal antibodies, all built around your therapeutic antibody needs.

Come visit our booth, where we’ll be happy to walk you through our high-affinity, low off-rate anti-ID and anti-payload antibody development for your PK and ADA assay needs.

Come visit our booth to learn more. We’ll walk you through our therapeutic antibody development package, from antigen design through in vitro and in vivo assay support, including fully human monoclonal antibodies. It’s all built around your specific therapeutic antibody needs.